FDA Commissioner Defends Reaction To Avandia

The U.S. Food and Drug Administration has asked GlaxoSmithKline PLC, Takeda Pharmaceutical Co. and Eli Lilly & Company to add black box warnings—the strongest safety warning available—to diabetes drugs Avandia and...

Already a subscriber? Click here to view full article